Latest Eversept Partners, LP Stock Portfolio

$1.90Billion– No. of Holdings #105

Eversept Partners, LP Performance:

2026 Q1: -3.42%YTD: -3.42%2025: 19.86%

Performance for 2026 Q1 is -3.42%, and YTD is -3.42%, and 2025 is 19.86%.

About Eversept Partners, LP and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Eversept Partners, LP reported an equity portfolio of $1.9 Billions as of 31 Mar, 2026.

The top stock holdings of Eversept Partners, LP are UTHR, , GSK. The fund has invested 8.3% of it's portfolio in UNITED THERAPEUTICS CORP DEL and 5.5% of portfolio in ABIVAX SA.

The fund managers got completely rid off DANAHER CORPORATION (DHR), EXACT SCIENCES CORP (EXAS) and CIDARA THERAPEUTICS INC (CDTX) stocks. They significantly reduced their stock positions in TYRA BIOSCIENCES INC (TYRA), BRUKER CORP (BRKR) and ULTRAGENYX PHARMACEUTICAL IN (RARE). Eversept Partners, LP opened new stock positions in WELLTOWER INC (WELL), HEALTHPEAK PROPERTIES INC (PEAK) and OMEGA HEALTHCARE INVS INC (OHI). The fund showed a lot of confidence in some stocks as they added substantially to BROOKDALE SR LIVING INC (BKD), SAVARA INC (SVRA) and BIOMARIN PHARMACEUTICAL INC (BMRN).

Eversept Partners, LP Equity Portfolio Value

Last Reported on: 15 May, 2026

Eversept Partners, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Eversept Partners, LP made a return of -3.42% in the last quarter. In trailing 12 months, it's portfolio return was 27.61%.

Performance
S&P 500

New Buys

Ticker	$ Bought
welltower inc	35,776,200
healthpeak properties inc	32,549,000
omega healthcare invs inc	25,664,500
qiagen nv	21,835,000
repligen corp	14,230,900
ltc pptys inc	11,930,100
chemed corp new	11,731,500
viking therapeutics inc	7,780,640

New stocks bought by Eversept Partners, LP

Additions

Ticker	% Inc.
brookdale sr living inc	851
savara inc	125
biomarin pharmaceutical inc	121
beta bionics inc	108
insulet corp	92.14
encompass health corp	81.53
eli lilly & co	78.86
ss innovations international	46.18

Additions to existing portfolio by Eversept Partners, LP

Reductions

Ticker	% Reduced
tyra biosciences inc	-90.29
bruker corp	-85.07
ultragenyx pharmaceutical in	-80.27
anaptysbio inc	-77.6
assembly biosciences inc	-74.39
healthequity inc	-72.21
bio-techne corp	-66.64
bioventus inc	-66.24

Eversept Partners, LP reduced stake in above stock

Sold off

Ticker	$ Sold
mannkind corp	-10,504,000
select med hldgs corp	-13,455,600
maravai lifesciences hldgs i	-2,335,390
teva pharmaceutical inds ltd	-20,604,100
dynavax technologies corp	-9,319,910
catalyst pharmaceuticals inc	-8,359,640
evolus inc	-2,288,290
edgewise therapeutics inc	-8,371,090

Eversept Partners, LP got rid off the above stocks

Sector Distribution

Eversept Partners, LP has about 71% of it's holdings in Healthcare sector.

Healthcare
Others
Real Estate
Basic Materials

Sector	%
Healthcare	71
Others	20.1
Real Estate	7
Basic Materials	1.5

Market Cap. Distribution

Eversept Partners, LP has about 32.3% of it's portfolio invested in the large-cap and mega-cap stocks.

LARGE-CAP
MID-CAP
SMALL-CAP
UNALLOCATED
MICRO-CAP
MEGA-CAP

Category	%
LARGE-CAP	31.1
MID-CAP	23.2
SMALL-CAP	22.1
UNALLOCATED	20.1
MICRO-CAP	2
MEGA-CAP	1.2

Stocks belong to which Index?

About 49.3% of the stocks held by Eversept Partners, LP either belong to S&P 500 or RUSSELL 2000 index.

Others
RUSSELL 2000
S&P 500

Index	%
Others	50.7
RUSSELL 2000	37.4
S&P 500	11.9

Top 5 Winners (%)		%
STRO	sutro biopharma inc	79.4 %
MRNA	moderna inc	57.7 %
EHAB	enhabit inc	51.3 %
AADI	whitehawk therapeutics inc	38.1 %
ALEC	alector inc	31.5 %

Top 5 Winners ($)		$
UTHR	united therapeutics corp del	27.3 M
GSK	gsk plc	13.7 M
PCVX	vaxcyte inc	12.7 M
CLDX	celldex therapeutics inc new	7.3 M
SNDX	syndax pharmaceuticals inc	7.3 M

Top 5 Losers (%)		%
EHTH	ehealth inc	-71.7 %
	beta bionics inc	-60.1 %
SLQT	selectquote inc	-55.4 %
ADGI	invivyd inc	-46.6 %
BCYC	bicycle therapeutics plc	-33.8 %

Top 5 Losers ($)		$
VERA	vera therapeutics inc	-27.3 M
	beta bionics inc	-21.4 M
	abivax sa	-18.7 M
VRDN	viridian therapeutics inc	-14.4 M
AVTR	avantor inc	-11.1 M

Eversept Partners, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Eversept Partners, LP

Eversept Partners, LP has 105 stocks in it's portfolio. About 42.1% of the portfolio is in top 10 stocks. VERA proved to be the most loss making stock for the portfolio. UTHR was the most profitable stock for Eversept Partners, LP last quarter.

Last Reported on: 15 May, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
AADI	whitehawk therapeutics inc	0.06	306,800	1,058,460	added	17.88

ACAD	acadia pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

ADGI	invivyd inc	0.16	2,276,350	2,959,250	added	6.36

AGIO	agios pharmaceuticals inc	0.36	200,000	6,766,000	new

AGL	agilon health inc	0.07	7,063	1,396,810	new

AIRS	airsculpt technologies inc	0.01	74,139	209,813	new

ALEC	alector inc	0.15	1,351,110	2,904,880	added	34.28

AMRN	amarin corp plc	0.11	147,715	2,135,960	reduced	-14.21

ANAB	anaptysbio inc	0.08	40,633	1,502,360	reduced	-77.6

ANTX	elevance health inc formerly	0.00	0.00	0.00	sold off	-100

ARDX	ardelyx inc	0.70	2,229,450	13,354,400	added	29.99

ARQT	arcutis biotherapeutics inc	0.72	576,580	13,584,200	added	32.66

ASMB	assembly biosciences inc	0.06	40,889	1,134,670	reduced	-74.39

ASND	ascendis pharma a/s	0.00	0.00	0.00	sold off	-100

AVTR	avantor inc	1.23	2,974,290	23,318,400	reduced	-6.37

BCRX	biocryst pharmaceuticals inc	1.53	3,039,820	28,939,100	added	1.57

BCYC	bicycle therapeutics plc	0.05	190,715	884,918	added	6.6

BIIB	biogen inc	0.00	0.00	0.00	sold off	-100

BKD	brookdale sr living inc	2.57	3,568,560	48,817,800	added	851

BMRN	biomarin pharmaceutical inc	0.62	207,768	11,736,800	added	121